OVID: Ovid Therapeutics Inc Company Profile & Statistics

About

Ovid Therapeutics Inc. is a biopharmaceutical company. It engaged in developing therapies for patients with rare neurological disorders. The company's product pipeline consists of OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. It also involved in developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid Therapeutics Inc. is based in New York, United States.

Info & Links

CEO

Jeremy M. Levin

Headquarters

441 Ninth Avenue, 14th Floor
New York, NY 10001, UNITED STATES

Auditor

KPMG LLP

Share holders

Employees

Ovid Therapeutics Inc Statistics

Valuation Measures

Market Capitalization²

71.72M

Enterprise Value

71.78M

Enterprise Value/EBITDA(ttm)

-1.06

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

115.73

Price to Book(mrq)

0.96

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-5142.56%

Profit Margin(ttm)

-5442.16%

Return on Equity(ttm)

-39.24%

Return on Invested Capital(ttm)

-34.83%

Return on Assets(ttm)

-26.19%

Income Statement

Revenue(ttm)

631.70K

Revenue Per Share(ttm)

0.01

Gross Profit(ttm)

631.70K

EBITDA(ttm)³

-67.73M

Net Income Available to Common(ttm)

-32.50M

Diluted EPS(ttm)

-0.47

Share Statistics

Beta (5Y Monthly)

0.29

52-Week Change

-68.44%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

71.01M

Dividend Yield

0.00%

Float⁴

61.57M

% Held by Insiders

13.30%

% Held by Institutions

72.24%

Balance Sheet

Total Cash(mrq)

62.71M

Total Cash Per Share(mrq)

0.88

Total Debt(mrq)

15.07M

Total Debt/Equity(mrq)

19.76%

Current Ratio(mrq)

5.66%

Quick Ratio(mrq)

5.66%

Book Value Per Share(mrq)

1.07

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.65

Free Cash Flow(ytd)

-46.00M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

OVID

Ovid Therapeutics Inc

Ovid Therapeutics Inc Profile